These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

422 related items for PubMed ID: 21702649

  • 1. Triple inhalers for obstructive airways disease: will they be useful?
    Barnes PJ.
    Expert Rev Respir Med; 2011 Jun; 5(3):297-300. PubMed ID: 21702649
    [No Abstract] [Full Text] [Related]

  • 2. [Triple therapy in chronic obstructive pulmonary disease].
    Baloira A.
    Arch Bronconeumol; 2010 Jun; 46 Suppl 8():25-30. PubMed ID: 21334553
    [Abstract] [Full Text] [Related]

  • 3. COPD drugs: the urgent need for innovation.
    Vestbo J, Lange P.
    Lancet Respir Med; 2014 Jan; 2(1):14-5. PubMed ID: 24461887
    [No Abstract] [Full Text] [Related]

  • 4. [Triple fix-dose combination for treatment of COPD: convenient and effective].
    Worth H, Criée CP.
    Dtsch Med Wochenschr; 2016 Nov; 141(23):1668. PubMed ID: 27855451
    [No Abstract] [Full Text] [Related]

  • 5. M(2)-β(2) interaction: a basis for combined bronchodilator treatment.
    López-Campos JL.
    Arch Bronconeumol; 2013 Jul; 49(7):279-81. PubMed ID: 23122560
    [No Abstract] [Full Text] [Related]

  • 6. [Asthma and COPD: guidance in the jungle of inhalative drugs].
    Hering T.
    MMW Fortschr Med; 2015 May 28; 157(10):59, 61-2. PubMed ID: 26019099
    [No Abstract] [Full Text] [Related]

  • 7. Changes in inhaler devices for asthma and COPD.
    Capriotti T.
    Medsurg Nurs; 2005 Jun 28; 14(3):185-94. PubMed ID: 16035636
    [No Abstract] [Full Text] [Related]

  • 8. Ultra-LAMA, ultra-LABA, ultra-inhaled steroids? The future has landed.
    Domingo C.
    Arch Bronconeumol; 2013 Apr 28; 49(4):131-4. PubMed ID: 23415574
    [No Abstract] [Full Text] [Related]

  • 9. Seebri Neohaler and Utibron Neohaler for COPD.
    Med Lett Drugs Ther; 2016 Mar 28; 58(1491):39-41. PubMed ID: 27027687
    [No Abstract] [Full Text] [Related]

  • 10. Advances in drug delivery: Is triple therapy the future for the treatment of chronic obstructive pulmonary disease?
    Salama RO, Young PM, Rogueda P, Lallement A, Iliev I, Traini D.
    Expert Opin Pharmacother; 2011 Aug 28; 12(12):1913-32. PubMed ID: 21714776
    [Abstract] [Full Text] [Related]

  • 11. When to use single-inhaler triple therapy in COPD: a practical approach for primary care health care professionals.
    Gaduzo S, McGovern V, Roberts J, Scullion JE, Singh D.
    Int J Chron Obstruct Pulmon Dis; 2019 Aug 28; 14():391-401. PubMed ID: 30863039
    [Abstract] [Full Text] [Related]

  • 12. [Combined inhaled corticosteroid and long-acting beta-2-agonist in one inhaler in the treatment of chronic obstructive pulmonary disease].
    Pedersen ST.
    Ugeskr Laeger; 2005 Jun 06; 167(23):2504-6. PubMed ID: 16008004
    [No Abstract] [Full Text] [Related]

  • 13. Inhaled steroids and COPD.
    Cooper CB, Decramer M.
    Eur Respir J; 2008 Aug 06; 32(2):523-4. PubMed ID: 18669794
    [No Abstract] [Full Text] [Related]

  • 14. POINT: Should an Attempt Be Made to Withdraw Inhaled Corticosteroids in All Patients With Stable GOLD 3 (30% ≤ FEV1 < 50% Predicted) COPD? Yes.
    Chalmers JD.
    Chest; 2018 Apr 06; 153(4):778-782. PubMed ID: 29474807
    [No Abstract] [Full Text] [Related]

  • 15. The use of long acting β₂-agonists, alone or in combination with inhaled corticosteroids, in chronic obstructive pulmonary disease (COPD): a risk-benefit analysis.
    Cave AC, Hurst MM.
    Pharmacol Ther; 2011 May 06; 130(2):114-43. PubMed ID: 21276815
    [Abstract] [Full Text] [Related]

  • 16. COUNTERPOINT: Should an Attempt Be Made to Withdraw Inhaled Corticosteroids in All Patients With Stable GOLD 3 (30% ≤ FEV1 < 50% Predicted) COPD? No.
    Pavord ID.
    Chest; 2018 Apr 06; 153(4):782-784. PubMed ID: 29410364
    [No Abstract] [Full Text] [Related]

  • 17. The future of combining inhaled drugs for COPD.
    Bjerg A, Lundbäck B, Lötvall J.
    Curr Opin Pharmacol; 2012 Jun 06; 12(3):252-5. PubMed ID: 22465638
    [Abstract] [Full Text] [Related]

  • 18. Future of chronic obstructive pulmonary disease management.
    D'Urzo A, Vogelmeier C.
    Expert Rev Respir Med; 2012 Jun 06; 6(3):285-99. PubMed ID: 22788943
    [Abstract] [Full Text] [Related]

  • 19. Pharmacological management--inhaled treatment.
    Currie GP, Lipworth BJ.
    BMJ; 2006 Jun 17; 332(7555):1439-41. PubMed ID: 16777889
    [No Abstract] [Full Text] [Related]

  • 20. Triple therapy vs. dual bronchodilator therapy for chronic obstructive pulmonary disease: Is it worth the cost?
    Horita N, Kaneko T.
    Respir Investig; 2015 Jul 17; 53(4):173-5. PubMed ID: 26100178
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.